SYS-CON MEDIA Authors: Gilad Parann-Nissany, Kevin Benedict, Unitiv Blog, Mark R. Hinkle, Glenn Rossman

News Feed Item

Sigma-Aldrich Announces Q4 and Full-year 2013 Earnings Conference Call

ST. LOUIS, Jan. 15, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, will hold its quarterly conference call to discuss fourth quarter and full-year 2013 financial results on Thursday, February 6, 2014, at 11:00 AM Eastern Time.

Conference call details:
Date:  February 6, 2014
Time:  11:00 AM EST
Conference ID#:  34455183

Listen and view the presentation slides via the Internet at http://investor.sigmaaldrich.com/ or call one of the following numbers for audio only:
Domestic:  (877) 266-0483
International:  (707) 287-9342

A replay of the call will be available from 02/06/2014 to 02/13/2014.  For the replay, please call (855) 859-2056 (Domestic) or (404) 537-3406 (International) and use Conference ID# 34455183 or go to http://investor.sigmaaldrich.com/ under "Presentations & Events."

About Sigma-Aldrich:  Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 200,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 38 countries, has more than 9,000 employees worldwide and had sales of $2.6 billion in 2012. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Sigma-Aldrich is a registered trademark of Sigma-Aldrich Co. LLC.

 

SOURCE Sigma-Aldrich Corporation

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.